{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:17:07Z","timestamp":1789427827496,"version":"build-2803163510"},"reference-count":34,"publisher":"Federa\u00e7\u00e3o das Associa\u00e7\u00f5es de Ginecologia e Obstetr\u00edcia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,3]]},"DOI":"10.61622\/rbgo\/2024rbgo38","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T14:37:40Z","timestamp":1718203060000},"source":"Crossref","is-referenced-by-count":15,"title":["Laser therapy for genitourinary syndrome of menopause: systematic review and meta-analysis of randomized controlled trial"],"prefix":"10.61622","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8393-6338","authenticated-orcid":false,"given":"Lisieux de Lourdes Martins N\u00f3brega","family":"Pessoa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7085-8788","authenticated-orcid":false,"given":"Amaxsell Thiago Barros de","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9131-1952","authenticated-orcid":false,"given":"Ayane Cristine Alves","family":"Sarmento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4511-4373","authenticated-orcid":false,"given":"Ana Paula","family":"Ferreira Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7615-416X","authenticated-orcid":false,"given":"Isis","family":"Kelly dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8630-6240","authenticated-orcid":false,"given":"Eduardo","family":"Pereira de Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4105-7535","authenticated-orcid":false,"given":"Kleyton Santos de","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8351-5119","authenticated-orcid":false,"given":"Ana Katherine","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8958-1344","authenticated-orcid":false,"given":"Ricardo Ney","family":"Cobucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"47794","reference":[{"issue":"4","key":"key20240612103735_B1","doi-asserted-by":"crossref","first-page":"e556","DOI":"10.1016\/j.clbc.2019.04.007","article-title":"The impact of vaginal laser treatment for genitourinary syndrome of menopause in breast cancer survivors: a systematic review and meta-analysis","volume":"19","author":"Jha","year":"2019","unstructured":"Jha S, Wyld L, Krishnaswamy PH. The impact of vaginal laser treatment for genitourinary syndrome of menopause in breast cancer survivors: a systematic review and meta-analysis. Clin Breast Cancer. 2019;19(4):e556-62. doi: 10.1016\/j.clbc.2019.04.007","journal-title":"Clin Breast Cancer"},{"key":"key20240612103735_B2","first-page":"767","article-title":"The 2022 hormone therapy position statement of The North American Menopause Society","volume-title":"Menopause","author":"The 2022 Hormone Therapy Position Statement of The North American Menopause Society Advisory Panel","year":"2022","unstructured":"The 2022 Hormone Therapy Position Statement of The North American Menopause Society Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-94. doi: 10.1097\/GME.0000000000002028"},{"issue":"5","key":"key20240612103735_B3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/GME.0000000000001260","article-title":"The burden of vulvovaginal atrophy on women's daily living: implications on quality of life from a face-to-face real-life survey","volume":"26","author":"Nappi","year":"2019","unstructured":"Nappi RE, Palacios S, Bruyniks N, Particco M, Panay N; EVES Study investigators. The burden of vulvovaginal atrophy on women's daily living: implications on quality of life from a face-to-face real-life survey. Menopause. 2019;26(5):485-91. doi: 10.1097\/GME.0000000000001260","journal-title":"Menopause"},{"issue":"10","key":"key20240612103735_B4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11934-018-0831-y","article-title":"Laser therapy for genitourinary syndrome of menopause","volume":"19","author":"Rabley","year":"2018","unstructured":"Rabley A, O'Shea T, Terry R, Byun S, Moy ML. Laser therapy for genitourinary syndrome of menopause. Curr Urol Rep. 2018;19(10):83. doi: 10.1007\/s11934-018-0831-y","journal-title":"Curr Urol Rep"},{"issue":"2","key":"key20240612103735_B5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.maturitas.2014.02.015","article-title":"Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: a randomised, placebo-controlled, phase III trial","volume":"78","author":"Portman","year":"2014","unstructured":"Portman D, Palacios S, Nappi RE, Mueck AO. Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: a randomised, placebo-controlled, phase III trial. Maturitas. 2014;78(2):91-8. doi: 10.1016\/j.maturitas.2014.02.015","journal-title":"Maturitas"},{"issue":"4","key":"key20240612103735_B6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1089\/jwh.2007.0407","article-title":"A retrospective managed care claims data analysis of medication adherence to vaginal estrogen therapy: implications for clinical practice","volume":"17","author":"Shulman","year":"2008","unstructured":"Shulman LP, Portman DJ, Lee WC, Balu S, Joshi AV, Cobden D, et al. A retrospective managed care claims data analysis of medication adherence to vaginal estrogen therapy: implications for clinical practice. J Womens Health (Larchmt). 2008;17(4):569-78. doi: 10.1089\/jwh.2007.0407","journal-title":"J Womens Health (Larchmt)"},{"issue":"4","key":"key20240612103735_B7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/13697137.2014.899347","article-title":"A 12- week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study","volume":"17","author":"Salvatore","year":"2014","unstructured":"Salvatore S, Nappi RE, Zerbinati N, Calligaro A, Ferrero S, Origoni M, et al. A 12- week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Climacteric. 2014;17(4):363-9. doi: 10.3109\/13697137.2014.899347","journal-title":"Climacteric"},{"issue":"1","key":"key20240612103735_B8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/GME.0000000000001416","article-title":"A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: the VeLVET trial","volume":"27","author":"Paraiso","year":"2020","unstructured":"Paraiso MF, Ferrando CA, Sokol ER, Rardin CR, Matthews CA, Karram MM, et al. A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: the VeLVET trial. Menopause. 2020;27(1):50-6. doi: 10.1097\/GME.0000000000001416","journal-title":"Menopause"},{"issue":"4","key":"key20240612103735_B9","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.maturitas.2015.08.001","article-title":"Genitourinary syndrome of menopause and the use of laser therapy","volume":"82","author":"Hutchinson-Colas","year":"2015","unstructured":"Hutchinson-Colas J, Segal S. Genitourinary syndrome of menopause and the use of laser therapy. Maturitas. 2015;82(4):342-5. doi: 10.1016\/j.maturitas.2015.08.001","journal-title":"Maturitas"},{"issue":"9","key":"key20240612103735_B10","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.32563","article-title":"Comparison of severity of genitourinary syndrome of menopause symptoms after carbon dioxide laser vs vaginal estrogen therapy: a systematic review and meta-analysis","volume":"5","author":"Jang","year":"2022","unstructured":"Jang YC, Leung CY, Huang HL. Comparison of severity of genitourinary syndrome of menopause symptoms after carbon dioxide laser vs vaginal estrogen therapy: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(9):e2232563. doi: 10.1001\/jamanetworkopen.2022.32563","journal-title":"JAMA Netw Open"},{"issue":"2","key":"key20240612103735_B11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ijgo.13973","article-title":"Efficacy of CO2 laser treatment in postmenopausal women with vulvovaginal atrophy: a meta-analysis","volume":"158","author":"Liu","year":"2022","unstructured":"Liu M, Li F, Zhou Y, Cao Y, Li S, Li Q. Efficacy of CO2 laser treatment in postmenopausal women with vulvovaginal atrophy: a meta-analysis. Int J Gynaecol Obstet. 2022;158(2):241-51. doi: 10.1002\/ijgo.13973","journal-title":"Int J Gynaecol Obstet"},{"key":"key20240612103735_B12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.maturitas.2021.06.005","article-title":"Vaginal laser therapy for genitourinary syndrome of menopause - systematic review","volume":"156","author":"Mension","year":"2022","unstructured":"Mension E, Alonso I, Tortaja M, Matas I, G\u00f3mez S, Ribera L, et al. Vaginal laser therapy for genitourinary syndrome of menopause - systematic review. Maturitas. 2022;156:37-59. doi: 10.1016\/j.maturitas.2021.06.005","journal-title":"Maturitas"},{"issue":"11","key":"key20240612103735_B13","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1097\/GME.0000000000001845","article-title":"Vaginal CO2 laser therapy versus sham for genitourinary syndrome of menopause management: a systematic review and meta-analysis of randomized controlled trials","volume":"28","author":"Khamis","year":"2021","unstructured":"Khamis Y, Abdelhakim AM, Labib K, Islam BA, Nassar SA, Motaal AO, et al. Vaginal CO2 laser therapy versus sham for genitourinary syndrome of menopause management: a systematic review and meta-analysis of randomized controlled trials. Menopause. 2021;28(11):1316-22. doi: 10.1097\/GME.0000000000001845","journal-title":"Menopause"},{"issue":"3","key":"key20240612103735_B14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/13697137.2021.1990258","article-title":"Use of a vaginal CO2 laser for the management of genitourinary syndrome of menopause in gynecological cancer survivors: a systematic review","volume":"25","author":"Mejia-Gomez","year":"2022","unstructured":"Mejia-Gomez J, Bouteaud J, Philippopoulos E, Wolfman W, Brezden-Masley C. Use of a vaginal CO2 laser for the management of genitourinary syndrome of menopause in gynecological cancer survivors: a systematic review. Climacteric. 2022;25(3):228-34. doi: 10.1080\/13697137.2021.1990258","journal-title":"Climacteric"},{"key":"key20240612103735_B15","volume-title":"Cochrane handbook for systematic reviews of interventions. Version 6.3","author":"Higgins","year":"2022","unstructured":"Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al., editors. Cochrane handbook for systematic reviews of interventions. Version 6.3. Chichester: John Wiley & Sons; 2022 [cited 2023 Jan 12]. Available from: www.training.cochrane.org\/handbook"},{"key":"key20240612103735_B16","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"key20240612103735_B17","doi-asserted-by":"crossref","first-page":"772690","DOI":"10.3389\/frph.2021.772690","article-title":"Efficacy and safety of laser therapy for the treatment of genitourinary syndrome of menopause: a protocol for systematic review and meta-analysis of clinical trials","volume":"3","author":"Pessoa","year":"2021","unstructured":"Pessoa LL, Sarmento AC, Medeiros KS, Costa AP, Gon\u00e7alves AK, Cobucci RN. Efficacy and safety of laser therapy for the treatment of genitourinary syndrome of menopause: a protocol for systematic review and meta-analysis of clinical trials. Front Reprod Health. 2021;3:772690. doi: 10.3389\/frph.2021.772690","journal-title":"Front Reprod Health"},{"issue":"10","key":"key20240612103735_B18","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/GME.0000000000000329","article-title":"Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society","volume":"21","author":"Portman","year":"2014","unstructured":"Portman DJ, Gass ML; Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Menopause. 2014;21(10):1063-8. doi: 10.1097\/GME.0000000000000329","journal-title":"Menopause"},{"issue":"2","key":"key20240612103735_B19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/009262300278597","article-title":"The Female Sexual Function Sexual Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function","volume":"26","author":"Rosen","year":"2000","unstructured":"Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The Female Sexual Function Sexual Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191-208. doi: 10.1080\/009262300278597","journal-title":"J Sex Marital Ther"},{"issue":"3","key":"key20240612103735_B20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.34172\/jlms.2020.49","article-title":"The effect of the CO2 fractional laser or premarin vaginal cream on improving sexual function in menopausal women: a randomized controlled trial","volume":"11","author":"Eftekhar","year":"2020","unstructured":"Eftekhar T, Forooghifar T, Khalili T, Shariat M, Haghollahi F. The effect of the CO2 fractional laser or premarin vaginal cream on improving sexual function in menopausal women: a randomized controlled trial. J Lasers Med Sci. 2020;11(3):292-8. doi: 10.34172\/jlms.2020.49","journal-title":"J Lasers Med Sci"},{"issue":"10","key":"key20240612103735_B21","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston","year":"2019","unstructured":"Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019;10(10):ED000142. doi: 10.1002\/14651858.ED000142","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"key20240612103735_B22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jclinepi.2012.08.001","article-title":"GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes","volume":"66","author":"Guyatt","year":"2013","unstructured":"Guyatt GH, Thorlund K, Oxman AD, Walter SD, Patrick D, Furukawa TA, et al. GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes. J Clin Epidemiol. 2013;66(2):173-83. doi: 488 10.1016\/j.jclinepi.2012.08.001","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"key20240612103735_B23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/13697137.2020.1829584","article-title":"CO2 laser and the genitourinary syndrome of menopause: a randomized sham-controlled trial","volume":"24","author":"Salvatore","year":"2021","unstructured":"Salvatore S, Pitsouni E, Grigoriadis T, Zacharakis D, Pantaleo G, Candiani M, et al. CO2 laser and the genitourinary syndrome of menopause: a randomized sham-controlled trial. Climacteric. 2021;24(2):187-93. doi: 10.1080\/13697137.2020.1829584","journal-title":"Climacteric"},{"issue":"4","key":"key20240612103735_B24","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jsxm.2021.01.188","article-title":"A double-blind randomized sham-controlled trial to evaluate the efficacy of fractional carbon dioxide laser therapy on genitourinary syndrome of menopause","volume":"18","author":"Cruff","year":"2021","unstructured":"Cruff J, Khandwala S. A double-blind randomized sham-controlled trial to evaluate the efficacy of fractional carbon dioxide laser therapy on genitourinary syndrome of menopause. J Sex Med. 2021;18(4):761-9. doi: 10.1016\/j.jsxm.2021.01.188","journal-title":"J Sex Med"},{"key":"key20240612103735_B25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.maturitas.2019.04.124","article-title":"The effect of vaginal Erbium-YAG laser treatment for the genitourinary syndrome of menopause: a randomized controlled study","volume":"124","author":"Singwongsa","year":"2019","unstructured":"Singwongsa A, Vallibhakara O. The effect of vaginal Erbium-YAG laser treatment for the genitourinary syndrome of menopause: a randomized controlled study. Maturitas. 2019;124:153-4. doi: 10.1016\/j.maturitas.2019.04.124","journal-title":"Maturitas"},{"issue":"14","key":"key20240612103735_B26","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/jama.2021.14892","article-title":"Effect of fractional carbon dioxide laser vs sham treatment on symptom severity in women with postmenopausal vaginal symptoms: a randomized clinical trial","volume":"326","author":"Li","year":"2021","unstructured":"Li FG, Maheux-Lacroix S, Deans R, Nesbitt-Hawes E, Budden A, Nguyen K, et al. Effect of fractional carbon dioxide laser vs sham treatment on symptom severity in women with postmenopausal vaginal symptoms: a randomized clinical trial. JAMA. 2021;326(14):1381-9. doi: 10.1001\/jama.2021.14892","journal-title":"JAMA"},{"issue":"8","key":"key20240612103735_B27","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/GME.0000000000001542","article-title":"Treatment for vaginal atrophy using microablative fractional CO2 laser: a randomized double-blinded sham-controlled trial","volume":"27","author":"Ruanphoo","year":"2020","unstructured":"Ruanphoo P, Bunyavejchevin S. Treatment for vaginal atrophy using microablative fractional CO2 laser: a randomized double-blinded sham-controlled trial. Menopause. 2020;27(8):858-63. doi: 10.1097\/GME.0000000000001542","journal-title":"Menopause"},{"key":"key20240612103735_B28","first-page":"S12","article-title":"A double-blind randomised controlled trial of microablative fractional CO2 laser vs sham therapy on sexual function of women with vulvovagina atrophy (VVA): an interim analysis","volume":"36","author":"Girardelli","year":"2017","unstructured":"Girardelli S, Pitsouni E, Athanasiou S, Marotta E, Candiani M, Salvatore S. A double-blind randomised controlled trial of microablative fractional CO2 laser vs sham therapy on sexual function of women with vulvovagina atrophy (VVA): an interim analysis. Neurourol Urodyn. 2017;36 Suppl 2:S12-3. doi: 10.1002\/nau.23302","journal-title":"Neurourol Urodyn"},{"issue":"8","key":"key20240612103735_B29","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/lsm.23220","article-title":"Efficacy of fractional CO2 laser, promestriene, and vaginal lubricant in the treatment of urinary symptoms in postmenopausal women: a randomized clinical trial","volume":"52","author":"Aguiar","year":"2020","unstructured":"Aguiar LB, Politano CA, Costa-Paiva L, Juliato CR. Efficacy of fractional CO2 laser, promestriene, and vaginal lubricant in the treatment of urinary symptoms in postmenopausal women: a randomized clinical trial. Lasers Surg Med. 2020;52(8):713-20. doi: 10.1002\/lsm.23220","journal-title":"Lasers Surg Med"},{"issue":"1","key":"key20240612103735_B30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/GME.0000000000000955","article-title":"Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women","volume":"25","author":"Cruz","year":"2018","unstructured":"Cruz VL, Steiner ML, Pompei LM, Strufaldi R, Fonseca FL, Santiago LH, et al. Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women. Menopause. 2018;25(1):21-8. doi: 10.1097\/GME.0000000000000955","journal-title":"Menopause"},{"issue":"8","key":"key20240612103735_B31","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/GME.0000000000001333","article-title":"Fractional CO2 laser versus promestriene and lubricant in genitourinary syndrome of menopause: a randomized clinical trial","volume":"26","author":"Politano","year":"2019","unstructured":"Politano CA, Costa-Paiva L, Aguiar LB, Machado HC, Baccaro LF. Fractional CO2 laser versus promestriene and lubricant in genitourinary syndrome of menopause: a randomized clinical trial. Menopause. 2019;26(8):833-40. doi: 10.1097\/GME.0000000000001333","journal-title":"Menopause"},{"issue":"3","key":"key20240612103735_B32","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/1471-0528.17335","article-title":"Laser versus sham for genitourinary syndrome of menopause: a randomised controlled trial","volume":"130","author":"Page","year":"2023","unstructured":"Page AS, Verbakel JY, Verhaeghe J, Latul YP, Housmans S, Deprest J. Laser versus sham for genitourinary syndrome of menopause: a randomised controlled trial. BJOG. 2023;130(3):312-9. doi: 10.1111\/1471-0528.17335","journal-title":"BJOG"},{"issue":"3","key":"key20240612103735_B33","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jsxm.2021.12.010","article-title":"CO2-laser therapy and genitourinary syndrome of menopause: a systematic review and meta-analysis","volume":"19","author":"Filippini","year":"2022","unstructured":"Filippini M, Porcari I, Ruffolo AF, Casiraghi A, Farinelli M, Uccella S, et al. CO2-laser therapy and genitourinary syndrome of menopause: a systematic review and meta-analysis. J Sex Med. 2022;19(3):452-70. doi: 10.1016\/j.jsxm.2021.12.010","journal-title":"J Sex Med"},{"key":"key20240612103735_B34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.maturitas.2017.06.029","article-title":"Laser therapy for the genitourinary syndrome of menopause. A systematic review and meta-analysis","volume":"103","author":"Pitsouni","year":"2017","unstructured":"Pitsouni E, Grigoriadis T, Falagas ME, Salvatore S, Athanasiou S. Laser therapy for the genitourinary syndrome of menopause. A systematic review and meta-analysis. Maturitas. 2017;103:78-88. doi: 10.1016\/j.maturitas.2017.06.029","journal-title":"Maturitas"}],"container-title":["Revista Brasileira de Ginecologia e Obstetr\u00edcia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journalrbgo.org\/wp-content\/uploads\/sites\/4\/articles_xml\/1806-9339-rbgo-46-e-rbgo38\/1806-9339-rbgo-46-e-rbgo38.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T16:52:39Z","timestamp":1724345559000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalrbgo.org\/article\/laser-therapy-for-genitourinary-syndrome-of-menopause-systematic-review-and-meta-analysis-of-randomized-controlled-trial\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":34,"alternative-id":["10.61622\/rbgo\/2024rbgo38"],"URL":"https:\/\/doi.org\/10.61622\/rbgo\/2024rbgo38","relation":{},"ISSN":["0100-7203","1806-9339"],"issn-type":[{"value":"0100-7203","type":"print"},{"value":"1806-9339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e-rbgo38"}}